OP0339 TOCILIZUMAB IN GIANT CELL ARTERITIS. MONOTHERAPY VERSUS COMBINED WITH CONVENTIONAL IMMUNOSUPPRESSIVE DRUGS Conference Paper 2019 Congress communication

https://ard-bmj-com.m-ser.a17.csinet.es/content/annrheumdis/78/Suppl_2/252.3.full.pdf

Overview
Additional Document Info
Otro
Ver todos

authors

publication date

2019

output of process or event

EULAR EUROPEAN CONGRESS OF RHEUMATOLOGY Conference